Bevacizumab and Temozolomide or Bevacizumab and Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed by Surgery

NCT00626405 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

95

Enrollment

OTHER

Sponsor class

Conditions

Melanoma (Skin)

Interventions

BIOLOGICAL: bevacizumab
DRUG: carboplatin
DRUG: paclitaxel albumin-stabilized nanoparticle formulation
DRUG: temozolomide

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]